---
title: "Eli Lilly, Dell Among Stocks To Watch As Market Leadership Shifts"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293823751.md"
description: "Investors are shifting away from AI-related stocks as they weaken, turning towards sectors like energy and health care instead. Companies like Eli Lilly and Dell are gaining attention as potential stocks to watch amidst this market leadership shift."
datetime: "2026-07-25T13:19:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293823751.md)
  - [en](https://longbridge.com/en/news/293823751.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293823751.md)
generator: "portal-rs"
---

# Eli Lilly, Dell Among Stocks To Watch As Market Leadership Shifts

Investors are shifting away from AI-related stocks as they weaken, turning towards sectors like energy and health care instead. Companies like Eli Lilly and Dell are gaining attention as potential stocks to watch amidst this market leadership shift.

### Related Stocks

- [DELL.US](https://longbridge.com/en/quote/DELL.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [DLLL.US](https://longbridge.com/en/quote/DLLL.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)

## Related News & Research

- [Dell is now the most important stock in the market. Here's why](https://longbridge.com/en/news/297802617.md)
- [Eli Lilly's Taltz-Zepbound Combo Shows Encouraging Results At Week 52](https://longbridge.com/en/news/297510647.md)
- [Lilly's $9.94 Billion Mounjaro Franchise Wins a Heart-Risk Label](https://longbridge.com/en/news/297356212.md)
- [Key facts: DELL posts record Q2, raises FY27 to $192B; $6.25B pledge](https://longbridge.com/en/news/297746468.md)
- [Evolve Private Wealth LLC Lowers Stock Holdings in Eli Lilly and Company $LLY](https://longbridge.com/en/news/297282696.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**